Sorilux
Active Ingredient(s): CalcipotrieneFDA Approved: * October 6, 2010
Pharm Company: * STIEFEL LABS INC
Category: Skin Care
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Sorilux Overview
Calcipotriol, also known as calcipotriene, is a synthetic derivative of calcitriol, a form of vitamin D. It is used in the treatment of psoriasis. It is safe for long-term application in psoriatic skin conditions. It was patented in 1985 and approved for medical use in 1991.[1] It is marketed under the trade name "Dovonex" in the United States, "Daivonex" outside North America, and "Psorcutan" in Germany. Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Inter...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Calcipotriol
Recent Sorilux Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Calcipotriene
- Aerosol, Foam: 0.005%
- Cream: 0.005%, 0.01%
- Foam: 0.01%
- Ointment: 0.005%, 0.01%
- Solution: 0.005%, 0.01%
NDC Database Records for Sorilux: (2 results)
Sorted by National Drug Code- 0145-2130 Sorilux 50 ug/g Topical Aerosol, Foam by Stiefel Laboratories Inc
- 51862-376 Sorilux 50 ug/g Topical Aerosol, Foam by Mayne Pharma LLC
Other drugs which contain Calcipotriene or a similar ingredient: (8 results)
- CALCIPOTRIENE
- DOVONEX Calcipotriene
- BETAMETHASONE DIPROPIONATE + CALCIPOTRIENE HYDRATE
- CALCIPOTRIENE + BETAMETHASONE DIPROPIONATE
- ENSTILAR Calcipotriene + Betamethasone Dipropionate
- TACLONEX Betamethasone Dipropionate + Calcipotriene Hydrate
- TACLONEX SCALP Calcipotriene + Betamethasone Dipropionate
- WYNZORA Betamethasone Dipropionate + Calcipotriene